(Q40436846)

20 September 2017

title

Tick-borne encephalitis virus neutralization by high dose intravenous immunoglobulin (English)

1 reference

tick-borne encephalitis virus

20 September 2017

main subject

tick-borne encephalitis

1 reference

based on heuristic

inferred from title

object named as

Tick-borne encephalitis virus

1 reference

Daniel Ruzek

6

0 references

Martin Palus

object named as

Martin Palus

series ordinal

2

0 references

Jana Širmarová

series ordinal

3

object named as

Jana Sirmarova

1 reference

20 September 2017

1

Jana Elsterova

1 reference

20 September 2017

Jan Kopecky

4

1 reference

20 September 2017

Hans Helmut Niller

series ordinal

5

1 reference

20 September 2017

publication date

18 November 2016

1 reference

Ticks and Tick-borne Diseases

20 September 2017

published in

1 reference

20 September 2017

volume

8

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

253-258

1 reference

A protective chimeric antibody to tick-borne encephalitis virus.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Intravenous immunoglobulin for infectious diseases: tailor-made or universal?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

High dose intravenous immunoglobulin treatment: mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Role of intravenous immunoglobulin administration in Japanese encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

A case of imported JE acquired during short travel in Vietnam. Are current recommendations about vaccination broader?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Serum time course of two brain-specific proteins, alpha(1) brain globulin and neuron-specific enolase, in tick-born encephalitis and Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Fatal tick-borne encephalitis in an immunosuppressed 12-year-old patient.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Case reports of neuro-Chikungunya in southern Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Analysis of specific IgG titers against tick-borne encephalitis in patients with primary antibody deficiency under immunoglobulin substitution therapy: impact of plasma donor origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

A case of immunotherapy-responsive eastern equine encephalitis with diffusion-weighted imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Tick-borne encephalitis and golden agers: position paper of the International Scientific Working Group on Tick-borne encephalitis (ISW-TBE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Elevation of matrix metalloproteinase-9 level in cerebrospinal fluid of tick-borne encephalitis patients is associated with IgG extravassation and disease severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Tickborne encephalitis despite specific immunoglobulin prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Antibody-dependent enhancement of tick-borne encephalitis virus infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

West Nile virus neutralization by US plasma-derived immunoglobulin products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Morphological changes in human neural cells following tick-borne encephalitis virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Tick-borne encephalitis virus-neutralizing antibodies in different immunoglobulin preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Intravenous immunoglobulins in the treatment of dengue illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Tick-borne encephalitis in the age of general mobility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

MRI-imaging and clinical findings of eleven children with tick-borne encephalitis and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TTBDIS.2016.11.007

10.1016/J.TTBDIS.2016.11.007

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference